AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 45 filers reported holding AEVI GENOMIC MEDICINE INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $5,000 | -75.0% | 27,317 | -2.8% | 0.00% | – |
| Q4 2018 | $20,000 | -42.9% | 28,115 | 0.0% | 0.00% | – |
| Q3 2018 | $35,000 | +12.9% | 28,115 | 0.0% | 0.00% | – |
| Q2 2018 | $31,000 | -57.5% | 28,115 | -22.0% | 0.00% | – |
| Q1 2018 | $73,000 | +114.7% | 36,022 | +28.1% | 0.00% | – |
| Q4 2017 | $34,000 | -2.9% | 28,115 | 0.0% | 0.00% | – |
| Q3 2017 | $35,000 | -5.4% | 28,115 | 0.0% | 0.00% | – |
| Q2 2017 | $37,000 | -82.4% | 28,115 | -75.1% | 0.00% | – |
| Q1 2017 | $210,000 | -64.0% | 112,786 | +0.1% | 0.00% | – |
| Q4 2016 | $583,000 | – | 112,637 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,070,000 | $1,990,000 | 0.99% |
| 22NW, LP | 155,000 | $288,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 405,000 | $753,000 | 0.15% |
| Broadfin Capital, LLC | 500,000 | $930,000 | 0.11% |
| DLD Asset Management, LP | 237,100 | $438,000 | 0.07% |
| Birchview Capital, LP | 68,000 | $126,000 | 0.07% |
| CARL DOMINO INC | 33,273 | $62,000 | 0.07% |
| R&F Capital Advisors LP | 84,268 | $157,000 | 0.04% |
| TFS CAPITAL LLC | 49,461 | $92,000 | 0.03% |
| SIMON QUICK ADVISORS, LLC | 24,390 | $45,000 | 0.03% |